Haemonetics

Global healthcare company dedicated to providing innovative medical products & solutions

04/24/2026

New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures: https://bit.ly/42qjK5p

04/21/2026

DYK that many people with Primary Immunodeficiency require plasma-derived therapies for treatment? If you’re able to give plasma, you can find a donation center here: https://bit.ly/4uPau7Z

04/20/2026

Haemonetics' VASCADE MVP® XL system received FDA approval for larger sheaths used in market-leading technologies for pulsed field ablation (PFA) and left atrial appendage closure (LAAC) to treat atrial fibrillation. It is now the only extravascular venous closure system clinically proven in electrophysiology procedures using up to 17F OD procedural sheaths. Learn more: https://bit.ly/4s5beDp

04/19/2026

At Haemonetics, we're proud to recognize Lab Week and celebrate the medical laboratory professionals who advance health care and advocate for patients. Your contributions make a profound difference, and we’re grateful to call you our partners.

ASCP

04/14/2026

A single-center observational study evaluating a TEG®-based intraoperative transfusion algorithm in adult cardiac surgical patients is now available. Following implementation of the viscoelastic-guided approach, investigators observed reductions in transfused blood products compared with historic controls. Studies like this highlight how viscoelastic testing can play an important role in standardizing transfusion practices and improving perioperative care. Access the article: https://bit.ly/4dIlr5j

04/13/2026

Haemonetics is proud to support plasma collection with user focused technologies that support donation efficiency, helping customers expand access to the plasma derived therapies many PI patients need. If you can donate, find a collection center: https://bit.ly/3NoIXcT

04/08/2026

Every plasma donation has the potential to improve the life of someone with Primary Immunodeficiency. There is always a need for plasma donations, so if you are able to donate, consider doing so during : https://bit.ly/3NoIXcT

04/07/2026

On , we celebrate the evidence-based innovation that helps to save lives, advance care and build healthier futures for all of us.

04/02/2026

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026:

03/31/2026

Congratulations to Eva Hellman, our Director of Clinical Affairs, for being named a 2026 Rising Star by the Healthcare Businesswomen's Association! Eva’s commitment to quality and excellence in everything she does has a meaningful impact on the work we do at Haemonetics to for the customers, donors and patients who rely on us.

03/30/2026

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System. VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies. https://bit.ly/4s5beDp

03/25/2026

During , we want to take a moment and say thank you to physicians everywhere. The dedication and passion you bring to work each day makes all the difference in meaningfully advancing patient care.

Address

125 Summer Street
Boston, MA
02110

Website

http://haemonetics.com/

Alerts

Be the first to know and let us send you an email when Haemonetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Haemonetics:

Shortcuts

Want your practice to be the top-listed Clinic in Boston?